Study guide

14.4 CT and Hybrid Imaging in Nuclear Medicine

Certified Nuclear Medicine Technologist CNMT

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

1.1 Current CNMT Exam Facts 1.2 How to Use This Guide

2 Radiation Physics Fundamentals

2.1 Radioactive Materials, Isotopes, and Decay Modes 2.2 Decay Calculations and Counting Statistics 2.3 Interactions of Radiation with Matter 2.4 Radiation Detector Types and Principles

3 Biological Effects & ALARA

3.1 Biological Effects of Radiation Exposure 3.2 ALARA and Protection Calculations 3.3 Dose Limits, Surveys, and Personal Monitoring

4 NRC & Regulatory Compliance

4.1 NRC Areas, Spills, Waste, and Records 4.2 Written Directives and DOT Shipping 4.3 EPA, OSHA, HIPAA, FDA, and USP Standards 4.4 Radioactive Waste Disposal and Regulatory Records

5 Generators & Kit Preparation

5.1 Radionuclide Generators and Quality Control 5.2 Radiopharmaceutical Kit Preparation 5.3 Radiopharmaceutical Quality Control

6 Tc-99m Diagnostic Agents

6.1 Tc-99m Cardiac Imaging Agents 6.2 Tc-99m Bone, Renal, and GU Agents 6.3 Tc-99m GI and Hepatobiliary Agents 6.4 Tc-99m CNS, Infection, and Labeled Cells

7 Non-Tc Diagnostic & PET Agents

7.1 Iodine and Indium Diagnostic Agents 7.2 Gallium, Thallium, Xenon, and Miscellaneous Agents 7.3 PET Radiopharmaceuticals 7.4 Neurologic, Breast, and Neuroendocrine PET Agents

8 Therapeutics, Adjuncts & Administration

8.1 Therapeutic Radiopharmaceuticals 8.2 Interventional and Adjunct Pharmaceuticals 8.3 Blood Labeling and Administration Techniques 8.4 Blockade, Comfort, and Gastrointestinal Adjunct Agents

9 Non-Imaging Instrumentation

9.1 Well Counters, Probes, and Survey Meters 9.2 Dose Calibrator Quality Control 9.3 Auxiliary and Patient Care Equipment

10 Imaging Systems & Quality Control

10.1 Gamma Camera Quality Control 10.2 SPECT and SPECT/CT Systems 10.3 PET and PET/CT Systems and QC 10.4 CT Systems, PACS, and Information Systems 10.5 CT Radiation Dose, Safety Alerts, and Protocol Optimization

11 Pulmonary, Bone, Oncology & Infection Imaging

11.1 Pulmonary Imaging Procedures 11.2 Bone and Musculoskeletal Imaging 11.3 Oncology Imaging Procedures 11.4 Infection Imaging Procedures

12 Renal, Endocrine & Hematopoietic Imaging

12.1 Renal and Genitourinary Imaging 12.2 Endocrine Imaging (Thyroid, Parathyroid, Adrenal) 12.3 Hematopoietic and Bone Marrow Imaging 12.4 Thyroid Uptake Measurement and Radioiodine Survey Technique

13 Cardiovascular Procedures

13.1 Myocardial Perfusion Imaging 13.2 Cardiac Function, Viability, and Special Studies 13.3 Exercise and Pharmacologic Stress Testing

14 GI, CNS, Therapy & Hybrid CT Procedures

14.1 Gastrointestinal Procedures 14.2 Central Nervous System Procedures 14.3 Radionuclide Therapy Procedures 14.4 CT and Hybrid Imaging in Nuclear Medicine 14.5 CSF Studies: Cisternography, Leak Localization, and Shunt Patency

15 Patient Care & Clinical Workflow

15.1 Patient Care, Education, and Consent 15.2 Scheduling and Radiopharmaceutical Procurement 15.3 Acquisition, Positioning, and Image Quality 15.4 Image Processing and Quantitative Analysis 15.5 Non-Imaging Studies: Specimens, Counting, and Error Analysis

14.4 CT and Hybrid Imaging in Nuclear Medicine

Key Takeaways Explain This Topic AI

Hybrid CT may be used for attenuation correction (AC), anatomic localization, or fully diagnostic CT—parameters and intent differ

Low-dose AC-CT prioritizes μ-maps for SPECT/PET quantification with minimal extra dose; it is often non-diagnostic for subtle CT pathology

Diagnostic CT on hybrid systems may use higher mA, contrast, and breath-hold techniques under appropriate supervision and protocols

NMT scope includes patient screening, positioning, co-registration checks, and recognizing when CT is AC-only versus diagnostic—not independent CT reporting beyond training/credentialing

Contrast safety requires allergy/history review and renal risk assessment (e.g., eGFR) when IV contrast is ordered; hydrate and follow contrast reaction protocols

Last updated: August 2026

14.4 CT and Hybrid Imaging in Nuclear Medicine

Quick Answer: Hybrid CT serves attenuation correction , anatomic localization , and sometimes diagnostic CT . Low-dose AC-CT ≠ full diagnostic CT. Screen contrast allergy and renal function when IV contrast is ordered. Always check co-registration before the patient leaves.

Domain IV/V items assume SPECT/CT and PET/CT . Know why the CT was run and which quality bar applies.

Three Roles of CT in Hybrid Imaging

CT role Intent Typical technique traits

Attenuation correction (AC) Build a μ-map for emission correction Low mA/kVp class; free-breathing often OK; limited diagnostic detail

Anatomic localization Fuse emission foci to organs/nodes/bone Low-to-moderate dose; may exceed pure AC quality slightly

Diagnostic CT Answer a CT clinical question Higher exposure, breath-holds, IV/oral contrast as ordered, thinner slices

Teaching rule: same gantry, different product. Do not describe low-dose AC-CT as a contrast-enhanced diagnostic abdomen/pelvis CT.

When Low-Dose AC-CT Is Used

Pure AC-CT is chosen when:

Emission quantification or uniform map is the priority (cardiac SPECT, many PET/CT oncology maps).

The patient already has a recent diagnostic CT/MRI and only fusion/AC is needed.

Dose minimization is emphasized (pediatrics, repeat responders).

Tech execution: center the patient identically for emission and CT; avoid metal when possible or document; use manufacturer AC workflow; re-scout if arms-up vs arms-down changes mid-exam. Truncation (arms in FOV incorrectly, large patients) causes AC artifacts—recognize streaking and edge brightening on fused images.

Diagnostic vs Non-Diagnostic CT and NMT Scope

  • Topic Practical meaning
  • Non-diagnostic / AC-localization CT Supports NM interpretation; limited standalone CT claims

Diagnostic CT Requires protocol, supervision, and often additional credentialing/state rules for CT operation and contrast

NMT role Position, select protocol under AU/radiologist direction, screen patients, recognize artifacts, escalate reactions

Not NMT role (unless dual-credentialed) Independent diagnostic CT reporting outside NM fusion context

Know your facility policy : who enters diagnostic CT parameters, who injects contrast, who manages extravasation. Exam stems often test scope awareness as much as kVp numbers.

Contrast Considerations

IV iodinated contrast improves diagnostic CT of vessels, organs, and nodes but is not required for pure AC.

  • Screen item Why
  • Prior contrast reaction Premedication or alternative pathway
  • eGFR / creatinine Renal risk for iodinated contrast; follow ACR-style institutional cutoffs
  • Metformin policy Hold/restart rules after contrast per lab protocol
  • Pregnancy / breastfeeding Policy-based counseling
  • IV site quality Power injector rates demand secure access

Oral contrast may be used for PET/CT abdomen localization in some protocols—coordinate timing so it does not create emission artifacts or patient intolerance during long uptake periods. PET-specific note: high-density barium can cause AC overcorrection artifacts; follow PET/CT contrast SOPs (often water-density agents preferred).

If a reaction occurs: stop injection, call emergency response, follow epinephrine/oxygen protocols per ACLS-capable team—NMTs initiate facility reaction algorithm, not improvisation.

Co-Registration Checks (High Yield)

Fusion errors create false “hot nodes” on the wrong rib or side.

Visual check: body contour of CT vs emission; liver dome, bladder, skin outline should match.

Motion: patient shifted between CT and PET/SPECT—repeat the CT or emission segment if severe.

Respiratory mismatch: free-breathing CT vs emission average can misplace diaphragm lesions—know breath-hold diagnostic CT may not match free-breathing PET.

Hardware: verify correct series is loaded for AC (not a prior day’s CT accidentally).

Manual registration tools: use only per training; document when auto-registration fails.

Cardiac SPECT/CT: misregistration of the μ-map can create false perfusion defects—review and realign before final processing.

Patient Screening and Safety Checklist

  • Checkpoint Action
  • Pregnancy Screen before any CT + NM combo
  • Claustrophobia / pain Plan immobilization, breaks, analgesia coordination
  • Arms position Match oncology PET arms-up standards unless shoulder pathology
  • Metal / devices Remove jewelry; document implants; expect streak artifact
  • Contrast allergy / eGFR Before IV contrast CT portion
  • Hydration / void Standard NM plus contrast nephropathy prevention when applicable
  • Dose records Capture CTDI/DLP or system dose metrics when the system provides them
  • ALARA for Hybrid CT

Even “low-dose” CT is real dose. Use AEC as protocolled, avoid duplicate diagnostic CT when policy allows reuse, and collimate Z-axis to the ordered FOV. Pediatrics need dedicated low-dose maps.

Hybrid Workflow Snapshot

  • Phase NM technologist focus
  • Order review AC-only vs localization vs diagnostic + contrast
  • Prep NM prep + CT/contrast screens
  • Emission Standard PET/SPECT quality
  • CT Correct protocol; breath-hold if diagnostic
  • Merge Co-registration QC
  • Finish Document contrast lot/volume if used
  • Common Artifact Pairings
  • Artifact Hybrid clue
  • AC overcorrection (metal/contrast) Hot rim on fusion at dense object
  • Truncation Edge bright/dark emission after AC
  • Misregistration Hot spot over wrong anatomy
  • Respiratory mismatch Liver-dome “swim” of lesions
  • Motion during CT Blurred μ-map → striped AC errors

Bottom line: name the CT purpose— AC, localization, or diagnostic —then screen, acquire, and prove fusion before release.